Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 4/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7934243 | 0.84 | KDM4E (0.52) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL893719 | 0.83 | SIRT6 (0.42) | SIRT6SIRT1GSRTLR2DPP8 | |
| SCHEMBL4272066 | 0.80 | GSR (0.52) | CPB2GSRDPP8DPP9DPP7 | |
| Acetylcysteine SCHEMBL663170 | 0.80 | BLM (0.62) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Acetylcysteine SCHEMBL663169 | 0.80 | BLM (0.62) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Acetylcysteine SCHEMBL893717 | 0.80 | BLM (0.62) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL7999610 | 0.80 | KDM4E (0.63) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL5599294 | 0.80 | KDM4E (0.63) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL7999598 | 0.80 | KDM4E (0.63) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL20240364 | 0.78 | GSR (0.61) | CPB2GSRDPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4169380-A1 | AGRICULTURAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF BACTERIAL DISEASES AND DISORDERS | Amazon Agrosciences Ltda (BR) | 2023-04-26 | — | — | EP | claimed |
| US-20210392886-A1 | Agricultural Composition for the Treatment and Prevention of Bacterial Diseases and Disorders | Instituto Agronômico (IAC) (BR) | 2021-12-23 | — | — | US | claimed |
| US-20160231323-A1 | PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY | Batu Biologics, Inc. (US) | 2016-08-11 | — | — | US | claimed |
| US-20140030323-A1 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | TIARA PHARMACEUTICALS, INC. (US) | 2014-01-30 | — | — | US | claimed |
| US-20140024857-A1 | CYSTEINE AMINO-ACID COMPOUND (OR ITS ANALOGUES) USED IN THE DISRUPTION OF MICROBIAL BIOFILMS WHEN TREATING OR PREVENTING DISEASES CAUSED BY PHYTOPATHOGENIC BACTERIA KNOWN TO ATTACK PLANTS OF AGRICULTURAL INTEREST | INSTITUTO AGRONOMICO DE CAMPINAS - IAC (BR) | 2014-01-23 | — | — | US | claimed |
| US-20120046232-A1 | COMPOSITIONS AND METHODS FOR REDUCING RELAPSE OF ADDICTIVE BEHAVIOR | MEDICAL UNIVERSITY OF SOUTH CAROLINA | 2012-02-23 | — | — | US | claimed |
| WO-2009137827-A2 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | TIARA PHARMACEUTICALS, INC. (US) | 2009-11-12 | — | — | WO | claimed |
| EP-1465614-B1 | A NUTRIENT PHARMACEUTICAL FORMULATION COMPRISING POLYPHENOLS AND USE IN TREATMENT OF CANCER | RATH MATTHIAS (NL) | 2008-01-02 | — | — | EP | claimed |
| EP-4169380-A1 | AGRICULTURAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF BACTERIAL DISEASES AND DISORDERS | Amazon Agrosciences Ltda (BR) | 2023-04-26 | — | — | EP | disclosed |
| CN-115315292-A | Compositions having thioredoxin activity and related methods | 奥普罗治疗公司 | 2022-11-08 | — | — | CN | disclosed |
| US-20210392886-A1 | Agricultural Composition for the Treatment and Prevention of Bacterial Diseases and Disorders | Instituto Agronômico (IAC) (BR) | 2021-12-23 | — | — | US | disclosed |
| US-20140030323-A1 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | TIARA PHARMACEUTICALS, INC. (US) | 2014-01-30 | — | — | US | disclosed |
| US-8524772-B2 | Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation | TIARA PHARMACEUTICALS, INC. (US) | 2013-09-03 | — | — | US | disclosed |
| US-20120046232-A1 | COMPOSITIONS AND METHODS FOR REDUCING RELAPSE OF ADDICTIVE BEHAVIOR | MEDICAL UNIVERSITY OF SOUTH CAROLINA | 2012-02-23 | — | — | US | disclosed |
| US-20110244045-A1 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | TIARA PHARMACEUTICALS ,INC. (US) | 2011-10-06 | — | — | US | disclosed |
| WO-2009137827-A2 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | TIARA PHARMACEUTICALS, INC. (US) | 2009-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140030323-A1 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | IL6, IL1B, NACA | KDM4E 4849/4885MAPT 2103/4885THRB 3934/4885 |
| US-20120046232-A1 | COMPOSITIONS AND METHODS FOR REDUCING RELAPSE OF ADDICTIVE BEHAVIOR | GRM6, GRM5, GRM7 | KDM4E 1271/4885MAPT 3237/4885THRB 1739/4885 |
| US-20110244045-A1 | CONTROLLED RELEASE OF N-ACETYLCYSTEINE (NAC) FOR REDUCTION OF SYSTEMIC AND/OR VASCULAR INFLAMMATION | IL6, IL1B, NACA | KDM4E 4849/4885MAPT 2103/4885THRB 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.